This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Evidence Impacts in the Model
- Available Evidence
- Rate of Eye exams
- Rate of Microalbuminuria
- Rate of Foot Exams
- Change in Systolic BP
- Change in Cholesterol
- Change In HbA1c
- No retinopathy to Photocoagulation to Blindness
Nephropathy to Microalbuminuria to Nephropathy to ESRD to Death
Neuropathy to Peripheral
Neuropathy to LEA to Hx LEA to Repeat
LEA to Death
- Foot ulcer rates
- No stroke to Stroke to Stroke Death
- No CHD to Angina to CA/MI to CHD Death
Note: highlight this is where management of diabetes impacts complications in our model.
Transition to next slide: This is where we are able to show value of ITDM.
Previous Slide Contents Next Slide